+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Selective Estrogen Receptor"

From
Selective Estrogen Receptor Degraders - Pipeline Insight, 2025 - Product Thumbnail Image

Selective Estrogen Receptor Degraders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Metastatic Breast Cancer Treatment Market Report 2025 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
HER2-Positive Breast Cancer Market Report 2025 - Product Thumbnail Image

HER2-Positive Breast Cancer Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Epithelial Ovarian Cancer Market Report 2025 - Product Thumbnail Image

Epithelial Ovarian Cancer Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Gynecology Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecology Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 386 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
HER2-Negative Breast Cancer Global Market Report 2025 - Product Thumbnail Image

HER2-Negative Breast Cancer Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Loading Indicator

The Selective Estrogen Receptor Modulators (SERMs) market is a subset of the Women's Health market, focusing on the use of SERMs to treat a variety of conditions related to female reproductive health. SERMs are a type of drug that can act as either an agonist or antagonist of the estrogen receptor, depending on the tissue type. This allows them to be used to treat conditions such as endometriosis, uterine fibroids, and menopausal symptoms. SERMs can also be used to reduce the risk of breast cancer and osteoporosis. SERMs are available in both oral and topical forms, and are often used in combination with other treatments. They are generally considered to be safe and effective, with few side effects. Some companies in the SERMs market include Pfizer, Novartis, AstraZeneca, and Eli Lilly. Show Less Read more